Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 3—March 2010
Dispatch

Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs

Clyde Dapat1Comments to Author , Yasushi Suzuki1, Reiko Saito, Yadanar Kyaw, Yi Yi Myint, Nay Lin, Htun Naing Oo, Khin Yi Oo, Ne Win, Makoto Naito, Go Hasegawa, Isolde C. Dapat, Hassan Zaraket, Tatiana Baranovich, Makoto Nishikawa, Takehiko Saito, and Hiroshi Suzuki
Author affiliations: Niigata University, Niigata, Japan (C. Dapat, Y. Suzuki, R. Saito, M. Naito, G. Hasegawa, I.C. Dapat, H. Zaraket, T. Baranovich, H. Suzuki); National Institute of Animal Health, Tsukuba City, Japan (T. Saito); Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata (M. Nishikawa); Sanpya Hospital, Yangon, Myanmar (Y. Kyaw); National Health Laboratory, Yangon (K.Y. Oo, N. Win); Central Myanmar Department of Medical Research, Nay Pyi Taw, Myanmar (Y.Y. Myint, N. Lin, H.N. Oo)

Main Article

Table

Characteristics of subtype H3N2 influenza viruses with Q136K mutation in NA and S31N substitution in M2*

Strains Passage history NA mutation IC50s of NA inhibitors
 Amantadine sensitivity† (M2 mutation)
Zanamivir, 
nM ± SD Fold change Oseltamivir, nM ± SD Fold change
All NAI-sensitive subtype H3N2 isolates‡ MDCK2 None 1.12 ± 0.40 1 0.86 ± 0.44 1 Resistant (S31N)
A/Myanmar/M187/2007 MDCK2 Q136K 59.72 ± 3.83 53.3 0.13 ± 0.05 0.2 Resistant (S31N)
A/Myanmar/M114/2008 MDCK2 Q136K 33.37 ± 7.02 29.8 0.16 ± 0.03 0.2 Resistant (S31N)
A/Texas/131/2002§ None 1.43 ± 0.09 1.3 0.99 ± 0.09 1.2 Sensitive
A/Texas/131/2002_E119V§ E119V 5.43 ± 0.68 4.8 94.33 ± 2.06 109.7 Sensitive

*NA, neuraminidase;IC50, inhibitory concentration; NAI, neuraminidase inhibitors.
†Amantadine sensitivity was based on M2 genotyping data.
‡Average IC50 was calculated excluding the control viruses (n = 47).
§Reference strains used as drug-sensitive and -resistant control viruses in the NAI assay.

Main Article

1These authors contributed equally to this article.

Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external